Showing results (821-830 of 7,008) with videos related to
Sort By:
Pageof 701
Lung Cancer (Amsterdam, Netherlands)|November 30, 2007
Stereotactic, high single-dose irradiation of stage I non-small cell lung cancer (NSCLC) using four-dimensional CT scans for treatment planningPeter Fritz, Hans-Jörg Kraus, Thomas Blaschke, et al.Lung Cancer (Amsterdam, Netherlands)|February 25, 2006
Differences in clinicopathological and biological features between central-type and peripheral-type squamous cell carcinoma of the lungTakamoto Saijo, Genichiro Ishii, Kanji Nagai, et al.Lung Cancer (Amsterdam, Netherlands)|February 28, 2006
Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphismAmelia Szymanowska, Ewa Jassem, Rafał Dziadziuszko, et al.Lung Cancer (Amsterdam, Netherlands)|February 28, 2006
Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapyThomas E Stinchcombe, David E Morris, Dominic T Moore, et al.Lung Cancer (Amsterdam, Netherlands)|December 28, 2007
Hybrid (intravenous and oral) administration of vinorelbine plus cisplatinum followed by oral vinorelbine as first-line therapy of advanced non-small cell lung cancer: a phase II studyA A Martoni, B Melotti, F Sperandi, et al.Lung Cancer (Amsterdam, Netherlands)|February 5, 2008
Serum vascular endothelial growth factor is related to systemic oxidative stress in patients with lung cancerA Katsabeki-Katsafli, T Kerenidi, K Kostikas, et al.Lung Cancer (Amsterdam, Netherlands)|February 5, 2008
Lung cancer screening--comparison of computed tomography and X-rayAyako Fujikawa, Yuichi Takiguchi, Satoko Mizuno, et al.Lung Cancer (Amsterdam, Netherlands)|December 7, 2007
Phase II study of plitidepsin in pretreated patients with locally advanced or metastatic non-small cell lung cancerChristian Peschel, Joerg T Hartmann, Alexander Schmittel, et al.Lung Cancer (Amsterdam, Netherlands)|December 7, 2007
Alteration of APE1/ref-1 expression in non-small cell lung cancer: the implications of impaired extracellular superoxide dismutase and catalase antioxidant systemsDae Goon Yoo, Yun Jeong Song, Eun Jung Cho, et al.Lung Cancer (Amsterdam, Netherlands)|December 7, 2007
Detection and comparison of epidermal growth factor receptor mutations in cells and fluid of malignant pleural effusion in non-small cell lung cancerXiaozhu Zhang, Yi Zhao, Miao Wang, et al.Pageof 701